Evidence map›Paper›PMID 41515838›Full record

ArticleMaterials (Basel, Switzerland)2026

Surface Engineering of Non-Equiatomic TiZrNbTaMo HEA by MAO Treatment in a Cu-Rich Electrolyte for Biomedical Applications.

Samuel P Bonetti, Jhuliene E M Torrento, Carlos R Grandini, Tiago Dos S P de Sousa, Gerson S de Almeida, Willian F Zambuzzi, Diego R N Correa

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuel P BonettiLaboratory of Anelasticity and Biomaterials, School of Sciences, Bauru Campus, São Paulo State University, Bauru 17033-360, Brazil.
Jhuliene E M TorrentoLaboratory of Anelasticity and Biomaterials, School of Sciences, Bauru Campus, São Paulo State University, Bauru 17033-360, Brazil.
Carlos R GrandiniLaboratory of Anelasticity and Biomaterials, School of Sciences, Bauru Campus, São Paulo State University, Bauru 17033-360, Brazil.ORCID 0000-0002-3336-309X
Tiago Dos S P de SousaBauru Campus, São Paulo State Technological College, Bauru 17033-360, Brazil.ORCID 0000-0002-9934-1870
Gerson S de AlmeidaDepartment of Chemistry and Biochemistry, Institute of Biosciences, São Paulo State University, Botucatu 18618-689, Brazil.ORCID 0000-0002-0208-0441
Willian F ZambuzziDepartment of Chemistry and Biochemistry, Institute of Biosciences, São Paulo State University, Botucatu 18618-689, Brazil.ORCID 0000-0002-4149-5965
Diego R N CorreaLaboratory of Anelasticity and Biomaterials, School of Sciences, Bauru Campus, São Paulo State University, Bauru 17033-360, Brazil.ORCID 0000-0002-1803-6488

Funding

CNPq #314.810/2021-8, #404020/2023-2, #421.677/2023-6, #408594/2024-1, #100704/2024-7, and #312391/2025-0FAPESP #2021/13921-3, #2024/03886-4, #2024/14878-2, and #2024/03148-3
6 · The paper itself

Abstract

This study evaluated the surface functionalization of a non-equiatomic TiZrNbTaMo high-entropy alloy (HEA) by micro-arc oxidation (MAO) in Cu-rich electrolytes to tailor its performance for biomedical implants. The Cu content was varied, and the resulting coatings were investigated for their morphology, phase constitution, chemical structure, wettability, and cytocompatibility. X-ray diffraction (XRD) measurements of the substrate indicated a body-centered cubic (BCC) matrix with minor HCP features, while the MAO-treated samples depicted amorphous halo with sparse reflections assignable to CaCO

Indexed as

biofunctionalizationcopperhigh entropy alloysmetallic biomaterialsmicro-arc oxidation

Identifiers

PMID41515838
PMCPMC12786585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.